InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

FEMASYS INC

FEMY Clue Score55
United States Fiscal year ends December CIK 0001339005
$2.00 -2.20% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.00 −71.91% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 18 Jun 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Revenue1.0Operating income−6.9Net income−6.9EPS, diluted−7.20Fiscal year 2021Revenue1.2 +13.7%Operating income−8.3Net income−7.5EPS, diluted−1.12Fiscal year 2022Revenue1.2 +2.2%Operating income−11.6Net income−11.4EPS, diluted−0.96Fiscal year 2023Revenue1.1 −11.1%Operating income−14.5Net income−14.2EPS, diluted−0.93Fiscal year 2024Revenue1.6 +52.0%Operating income−17.8Net income−18.8EPS, diluted−0.85Fiscal year 2025Revenue2.3 +40.8%Operating income−17.6Net income−18.6EPS, diluted−0.47
FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 1.0 1.2 1.2 1.1 1.6 2.3
Growth +13.7% +2.2% −11.1% +52.0% +40.8%
Operating income −6.9 −8.3 −11.6 −14.5 −17.8 −17.6
Net income −6.9 −7.5 −11.4 −14.2 −18.8 −18.6
Growth
EPS, diluted −7.20 −1.12 −0.96 −0.93 −0.85 −0.47

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2020Gross margin70.5%Operating margin−668.0%Net margin−666.2%Free cash flow margin−476.1%Fiscal year 2021Gross margin68.6%Operating margin−706.7%Net margin−639.0%Free cash flow margin−698.3%Fiscal year 2022Gross margin63.4%Operating margin−961.7%Net margin−944.6%Free cash flow margin−923.5%Fiscal year 2023Operating margin−1,353.4%Net margin−1,329.1%Free cash flow margin−1,065.7%Fiscal year 2024Operating margin−1,091.8%Net margin−1,155.0%Free cash flow margin−1,240.3%Fiscal year 2025Operating margin−767.0%Net margin−812.3%Free cash flow margin−837.9%
FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 70.5% 68.6% 63.4% n/a n/a n/a
Operating margin −668.0% −706.7% −961.7% −1,353.4% −1,091.8% −767.0%
Net margin −666.2% −639.0% −944.6% −1,329.1% −1,155.0% −812.3%
Free cash flow margin −476.1% −698.3% −923.5% −1,065.7% −1,240.3% −837.9%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow−4.9Capital expenditure−0.0Free cash flow−4.9Fiscal year 2021Operating cash flow−7.9Capital expenditure−0.3Free cash flow−8.2Fiscal year 2022Operating cash flow−10.7Capital expenditure−0.4Free cash flow−11.1Buybacks0.0Fiscal year 2023Operating cash flow−11.3Capital expenditure−0.1Free cash flow−11.4Buybacks−0.2Fiscal year 2024Operating cash flow−19.4Capital expenditure−0.8Free cash flow−20.2Buybacks−0.1Fiscal year 2025Operating cash flow−18.7Capital expenditure−0.5Free cash flow−19.2
FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −4.9 −7.9 −10.7 −11.3 −19.4 −18.7
Capital expenditure −0.0 −0.3 −0.4 −0.1 −0.8 −0.5
Free cash flow −4.9 −8.2 −11.1 −11.4 −20.2 −19.2
Growth
Buybacks n/a n/a 0.0 −0.2 −0.1 n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2020Cash3.3Shareholders’ equity−51.8Fiscal year 2021Cash24.8Shareholders’ equity26.3Fiscal year 2022Cash13.0Shareholders’ equity15.2Fiscal year 2023Cash21.7Shareholders’ equity18.4Fiscal year 2024Cash3.5Shareholders’ equity2.3Fiscal year 2025Cash9.3Shareholders’ equity5.9
FY2020FY2021FY2022FY2023FY2024FY2025
Cash 3.3 24.8 13.0 21.7 3.5 9.3
Shareholders’ equity −51.8 26.3 15.2 18.4 2.3 5.9

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022† 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025† 31 Dec 2025
Revenue and profit
1.0 1.2 1.2 1.1 1.6 2.3
Growth +13.7% +2.2% −11.1% +52.0% +40.8%
0.3 0.4 0.4 0.4 0.5 0.9
0.7 0.8 0.8 n/a n/a n/a
Growth +10.7% −5.6%
4.1 4.1 5.8 7.2 8.2 7.6
2.5 4.3 5.4 6.9 6.3 6.6
−6.9 −8.3 −11.6 −14.5 −17.8 −17.6
Growth
−6.9 −7.5 −11.4 −14.2 −18.8 −18.6
0.0 0.0 0.0 0.0 0.0 0.0
−6.9 −7.5 −11.4 −14.2 −18.8 −18.6
Growth
Per share
−7.20 −1.12 −0.96 −0.93 −0.85 −0.47
−7.20 −1.12 −0.96 −0.93 −0.85 −0.47
Growth
1.0 6.7 11.8 15.4 22.3 39.5
1.0 6.7 11.8 15.4 22.3 39.5
Growth +599.3% +76.0% +30.2% +44.7% +77.6%

† The diluted share count jumps at 2021 and 2022 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 17.2% a year over five years.
  • Operating margin is down 99.0 points on five years ago, at -767.0%.
  • A net loss in 6 of 6 years on file.